Cargando…

Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review

SIMPLE SUMMARY: This literature review shows preliminary evidence to suggest that electroporation, the use of electricity to cause the death of cells around the tumour, may be associated with an improved survival and complete resection rates following pancreatic surgery for higher stage pancreatic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratnayake, Bathiya, Al-Leswas, Dhya, Mohammadi-Zaniani, Ghazaleh, Littler, Peter, Sen, Gourab, Manas, Derek, Pandanaboyana, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268790/
https://www.ncbi.nlm.nih.gov/pubmed/34199031
http://dx.doi.org/10.3390/cancers13133212
_version_ 1783720434450038784
author Ratnayake, Bathiya
Al-Leswas, Dhya
Mohammadi-Zaniani, Ghazaleh
Littler, Peter
Sen, Gourab
Manas, Derek
Pandanaboyana, Sanjay
author_facet Ratnayake, Bathiya
Al-Leswas, Dhya
Mohammadi-Zaniani, Ghazaleh
Littler, Peter
Sen, Gourab
Manas, Derek
Pandanaboyana, Sanjay
author_sort Ratnayake, Bathiya
collection PubMed
description SIMPLE SUMMARY: This literature review shows preliminary evidence to suggest that electroporation, the use of electricity to cause the death of cells around the tumour, may be associated with an improved survival and complete resection rates following pancreatic surgery for higher stage pancreatic cancer. However, one in five patients have a complication from the procedure that alters their normal course in hospital. Moreover, the number of patients who underwent this technique is small and further data is needed to support the preliminary evidence. The results therefore should be interpreted with caution. ABSTRACT: The present systematic review aimed to summarise the available evidence on indications and oncological outcomes after MA IRE for stage III pancreatic cancer (PC). A literature search was performed in the Pubmed, MEDLINE, EMBASE, SCOPUS databases using the PRISMA framework to identify all MA IRE studies. Nine studies with 235 locally advanced (LA) (82%, 192/235) or Borderline resectable (BR) PC (18%, 43/235) patients undergoing MA IRE pancreatic resection were included. Patients were mostly male (56%) with a weighted-mean age of 61 years (95% CI: 58–64). Pancreatoduodenectomy was performed in 51% (120/235) and distal pancreatectomy in 49% (115/235). R0 resection rate was 73% (77/105). Clavien Dindo grade 3–5 postoperative complications occurred in 19% (36/187). Follow-up intervals ranged from 3 to 29 months. Local and systematic recurrences were noted in 8 and 43 patients, respectively. The weighted-mean progression free survival was 11 months (95% CI: 7–15). The weighted-mean overall survival was 22 months (95% CI 20–23 months) and 8 months (95% CI 1–32 months) for MA IRE and IRE alone, respectively. Early non-randomised data suggest MA IRE during pancreatic surgery for stage III pancreatic cancer may result in increased R0 resection rates and improved OS with acceptable postoperative morbidity. Further, larger studies are warranted to corroborate this evidence.
format Online
Article
Text
id pubmed-8268790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82687902021-07-10 Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review Ratnayake, Bathiya Al-Leswas, Dhya Mohammadi-Zaniani, Ghazaleh Littler, Peter Sen, Gourab Manas, Derek Pandanaboyana, Sanjay Cancers (Basel) Systematic Review SIMPLE SUMMARY: This literature review shows preliminary evidence to suggest that electroporation, the use of electricity to cause the death of cells around the tumour, may be associated with an improved survival and complete resection rates following pancreatic surgery for higher stage pancreatic cancer. However, one in five patients have a complication from the procedure that alters their normal course in hospital. Moreover, the number of patients who underwent this technique is small and further data is needed to support the preliminary evidence. The results therefore should be interpreted with caution. ABSTRACT: The present systematic review aimed to summarise the available evidence on indications and oncological outcomes after MA IRE for stage III pancreatic cancer (PC). A literature search was performed in the Pubmed, MEDLINE, EMBASE, SCOPUS databases using the PRISMA framework to identify all MA IRE studies. Nine studies with 235 locally advanced (LA) (82%, 192/235) or Borderline resectable (BR) PC (18%, 43/235) patients undergoing MA IRE pancreatic resection were included. Patients were mostly male (56%) with a weighted-mean age of 61 years (95% CI: 58–64). Pancreatoduodenectomy was performed in 51% (120/235) and distal pancreatectomy in 49% (115/235). R0 resection rate was 73% (77/105). Clavien Dindo grade 3–5 postoperative complications occurred in 19% (36/187). Follow-up intervals ranged from 3 to 29 months. Local and systematic recurrences were noted in 8 and 43 patients, respectively. The weighted-mean progression free survival was 11 months (95% CI: 7–15). The weighted-mean overall survival was 22 months (95% CI 20–23 months) and 8 months (95% CI 1–32 months) for MA IRE and IRE alone, respectively. Early non-randomised data suggest MA IRE during pancreatic surgery for stage III pancreatic cancer may result in increased R0 resection rates and improved OS with acceptable postoperative morbidity. Further, larger studies are warranted to corroborate this evidence. MDPI 2021-06-27 /pmc/articles/PMC8268790/ /pubmed/34199031 http://dx.doi.org/10.3390/cancers13133212 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Ratnayake, Bathiya
Al-Leswas, Dhya
Mohammadi-Zaniani, Ghazaleh
Littler, Peter
Sen, Gourab
Manas, Derek
Pandanaboyana, Sanjay
Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
title Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
title_full Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
title_fullStr Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
title_full_unstemmed Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
title_short Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review
title_sort margin accentuation irreversible electroporation in stage iii pancreatic cancer: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268790/
https://www.ncbi.nlm.nih.gov/pubmed/34199031
http://dx.doi.org/10.3390/cancers13133212
work_keys_str_mv AT ratnayakebathiya marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview
AT alleswasdhya marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview
AT mohammadizanianighazaleh marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview
AT littlerpeter marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview
AT sengourab marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview
AT manasderek marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview
AT pandanaboyanasanjay marginaccentuationirreversibleelectroporationinstageiiipancreaticcancerasystematicreview